Clinical Trials Sponsored by ArmaGen, Inc

Total 37007 results

Orfagen

Completed

Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)

Idiopathic Solar Urticaria

United States, United Kingdom
Orfagen

Completed

Efficacy, Local Tolerance and Patient Acceptability of a Moisturizing Emollient in Patients With Uremic Xerosis

Uremic Xerosis
Aldagen

Terminated

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases (UCBT-002)

Mucopolysaccharidosis | Inborn Errors of Metabolism | Lysosomal Storage Disorders | Inherited Metabolic Diseases | Peroxisomal Storage Diseases

United States
Aldagen

Unknown

Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects

Stroke | Ischemic Stroke | Stroke in Middle Cerebral Artery (MCA)

United States
Aldagen

Completed

ALD-301 for Critical Limb Ischemia, Randomized Trial (CLI-001)

Peripheral Arterial Disease | Peripheral Vascular Disease | Critical Limb Ischemia

United States
Orfagen

Completed

Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

Uremic Xerosis
Sumagen

Completed

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

HIV Infections

United States
Memorial Sloan Kettering Cancer Center
Aragon Pharmaceuticals, Inc.

Completed

ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate

Prostate Cancer

United States
Navire Pharma Inc., a BridgeBio company
Amgen

Recruiting

SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation (Argonaut)

Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLC

Spain, Australia, France, Denmark, Greece, Italy, Netherlands
ETOP IBCSG Partners Foundation
Amgen; Eisai Inc.

Withdrawn

AMG510 (Sotorasib) Plus Lenvatinib as Second-line Treatment in Patients With KRASG12C Mutant, Metastatic NSCLC (AMBER)

Metastatic Non Small Cell Lung Cancer | KRAS G12C

Spain, Switzerland, Austria, Germany
ECRI bv
GE Healthcare; Amgen; HeartFlow, Inc.

Withdrawn

Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion (MARKOV)

Coronary Artery Disease
Northwestern University
Genentech, Inc.; Amgen; OSI Pharmaceuticals

Completed

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Colorectal Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.; Amgen

Completed

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma

Non-Hodgkins Lymphoma

United States
Kreiskrankenhaus Dormagen

Completed

Influence of Analgesia and Neuromuscular Block on Abdominal Distension and Operating Conditions Laparoscopic Operations

Neuromuscular Blockade

Germany
Kreiskrankenhaus Dormagen

Completed

Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation

Feasibility of Measurement of a Neuromuscular Block at the m. Trapezius

Germany
Kreiskrankenhaus Dormagen

Recruiting

Evaluation of the New Acceleromyograph TOF 3D

Neuromuscular Block | Assessment of a New Acceleromyograph

Germany
Kreiskrankenhaus Dormagen

Completed

Influence of Neuromuscular Block on Mask Ventilation

Effect of a Neuromuscular Block on Ventilation

Germany
Kreiskrankenhaus Dormagen

Completed

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

Pain | Total Knee Arthroplasty

Germany
Kreiskrankenhaus Dormagen

Completed

Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium

Neuromuscular Block, Dexamethasone | Neuromuscular Block, Recovery

Germany
DermaGen AB

Completed

A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

Atopic Dermatitis

Sweden
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.; Amgen

Completed

Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

Breast Cancer

United States
Hoosier Cancer Research Network
Bayer; Genentech, Inc.; Amgen

Terminated

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
16 Bit Inc.
Sunnybrook Health Sciences Centre; Amgen

Recruiting

Clinical Deployment and Validation of Rho

Low Bone Density

Canada
UNC Lineberger Comprehensive Cancer Center
Amgen

Completed

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Melanoma | Melanoma (Skin) | Melanoma Stage Iv | Melanoma Stage Iii | Cutaneous Melanoma

United States
UNC Lineberger Comprehensive Cancer Center
Amgen

Withdrawn

Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

Head and Neck Cancer
Amager Hospital

Unknown

Acute Hamstring Strains in Danish Elite Soccer - Prevention and Rehabilitation

Strains
Amager Hospital

Completed

The Effect of Strength Training on the Hip Adduction Strength Measured With Hand-held Dynamometry

Hip Adduction Strength

Denmark
Amager Hospital

Completed

Hip-Flexion Strength Training: Can Elastic Bands Induce a Relevant Effect?

Hip Flexion Strength

Denmark
Amager Hospital

Unknown

Acute Hamstring Strains in Danish Elite Soccer - Diagnosis and Biomechanical Tests

Strains
Amager Hospital

Unknown

Prevention of Injuries by an Exercise Program - a RCT

Patellofemoral Pain Syndrome | Exertional Lower Leg Pain
Kaysen, George A., M.D., Ph.D.
Amgen; Dialysis Clinic, Inc.

Terminated

Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

End Stage Renal Disease

United States
Herbert Hurwitz, MD
Novartis; Genentech, Inc.; Amgen

Completed

BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) (BEP)

Solid Tumors

United States
AryoGen Pharmed Co.

Completed

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Factor VII Deficiency | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Glanzmann's Thrombasthenia

Iran, Islamic Republic of
AryoGen Pharmed Co.

Completed

Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency

Factor VII Deficiency

Iran, Islamic Republic of
AryoGen Pharmed Co.

Completed

Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Iran, Islamic Republic of
Amgen

Not yet recruiting

A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants

Basic Science
Amgen

Recruiting

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion

Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers

United States
Amgen

Not yet recruiting

A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight

Obesity
Amgen

Recruiting

AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)

Non-small Cell Lung Cancer | Thoracic Tumors

United States
Amgen

Recruiting

A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants

Atopic Dermatitis

United States, United Kingdom
Amgen

Not yet recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

Metastatic Colorectal Cancer
Amgen

Recruiting

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Sjögren's Syndrome (SS)

United States
Amgen

Not yet recruiting

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305)

Small-Cell Lung Cancer | Extensive-Stage Small-Cell Lung Cancer
Amgen

Recruiting

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD) (N-MOmentum LT)

Neuromyelitis Optica Spectrum Disorder

Korea, Republic of, Thailand, Hong Kong, Hungary, Poland
Amgen

Recruiting

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Advanced Solid Tumors

Australia, United States, Korea, Republic of
Amgen

Recruiting

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) (DeLLphi-306)

Small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer

Japan, Taiwan, China, United States, Turkey, Korea, Republic of
Amgen

Recruiting

A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Amgen

Not yet recruiting

Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

B Precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
Amgen

Recruiting

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

MTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid Tumors

United States, Australia

3

Subscribe